Search Contract Opportunities

Relenza (Zanamivir) Rotadisk, 5MG   2

ID: 75A50325C00019-JA • Type: Justification • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this solicitation list any subcontracting requirements?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Relenza (Zanamivir) Rotadisk, 5MG

Background
The Department of Health and Human Services (HHS), specifically the Assistant Secretary for Preparedness and Response (ASPR), is seeking to procure Relenza (Zanamivir) Rotadisk, 5MG to support the Strategic National Stockpile (SNS). This acquisition is essential for maintaining readiness in response to national emergencies, ensuring that the agency has the necessary antiviral medications available.

Work Details
The contract will involve a total procurement of Relenza (Zanamivir) Rotadisk, 5MG, which is exclusively manufactured by GlaxoSmithKline LLC. The awarded contract will be a five-year firm-fixed price contract consisting of one base year and four optional ordering periods. The procurement strategy aims to replenish stock as existing supplies near expiration and enhance preparedness for public health emergencies. The specific details include:
- Product: Relenza (Zanamivir) Rotadisk
- Dosage: 5MG
- Manufacturer: GlaxoSmithKline LLC
- Purpose: Materiel replenishment for SNS
- Contract Type: Firm-Fixed Price
- Duration: Five years with one base year and four optional years.

Period of Performance
The anticipated effective date of the contract is September 24, 2025, with a total duration of five years.

Place of Performance
The products will be delivered to locations designated by the Strategic National Stockpile.

Overview

Agency
HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) [HHS]
Award Date
Sept. 27, 2025
Response Deadline
None
Posted
Oct. 10, 2025, 10:14 a.m. EDT
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Durham, NC 27701 United States
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Value Range
$22,000,000 (value based on agency estimated range)
On 10/10/25 HHS Office of the Assistant Secretary for Preparedness and Response issued Justification 75A50325C00019-JA for Relenza (Zanamivir) Rotadisk, 5MG.
Primary Contact
Name
LaMonica Norwood   Profile
Email
oscontracting@hhs.gov
Phone
None

Documents

Posted documents for Justification 75A50325C00019-JA

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Justification 75A50325C00019-JA

Award Notifications

Agency published notification of awards for Justification 75A50325C00019-JA

Contract Awards

Prime contracts awarded through Justification 75A50325C00019-JA

Potential Bidders and Partners

Awardees that have won contracts similar to Justification 75A50325C00019-JA

Similar Active Opportunities

Open contract opportunities similar to Justification 75A50325C00019-JA

Experts for Relenza (Zanamivir) Rotadisk, 5MG

Recommended experts avaliable for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > ASPR/ORM-SNS
FPDS Organization Code
7505-75A503
Source Organization Code
500175942
Last Updated
Nov. 9, 2025
Last Updated By
lamonica.norwood@hhs.gov
Archive Date
Nov. 9, 2025